Quantbot Technologies LP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,548
+5.9%
1,516
-13.1%
0.00%
Q2 2023$4,293
+16.4%
1,745
+6.9%
0.00%
Q1 2023$3,688
-82.8%
1,632
-73.5%
0.00%
-100.0%
Q4 2022$21,457
-26.0%
6,148
+458.9%
0.00%
-33.3%
Q1 2022$29,000
-14.7%
1,100
-27.5%
0.00%0.0%
Q4 2021$34,000
-61.8%
1,517
-55.6%
0.00%
-57.1%
Q3 2021$89,0003,4170.01%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders